NDC 58284-264 – Brixadi
Buprenorphine 64 mg/.18mL · Injection · Subcutaneous
Product NDC58284-264
Product details
- Brand name
- Brixadi
- Generic name
- Buprenorphine
- Labeler
- Braeburn Inc.
- Dosage form
- Injection
- Route
- Subcutaneous
- Marketing category
- NDA · NDA210136
- Marketed since
- June 6, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Partial Opioid Agonist
Active ingredients
- Buprenorphine 64 mg/.18mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 58284-264-01 | 1 SYRINGE, GLASS in 1 CARTON (58284-264-01) / .18 mL in 1 SYRINGE, GLASS | Jun 6, 2023 |
Other Brixadi products
- 58284-208 Buprenorphine 8 mg/.16mL · Injection · Braeburn Inc.
- 58284-216 Buprenorphine 16 mg/.32mL · Injection · Braeburn Inc.
- 58284-224 Buprenorphine 24 mg/.48mL · Injection · Braeburn Inc.
- 58284-228 Buprenorphine 128 mg/.36mL · Injection · Braeburn Inc.
- 58284-232 Buprenorphine 32 mg/.64mL · Injection · Braeburn Inc.
- 58284-296 Buprenorphine 96 mg/.27mL · Injection · Braeburn Inc.